All Updates

All Updates

icon
Filter
Funding
Bluejay Diagnostics raises USD 8.75 million in underwritten public funding to settle outstanding debt obligations and advance clinical R&D
Precision Medicine
Jun 27, 2024
This week:
Partnerships
Abridge partners with Epic and Mayo Clinic for GenAI nurse workflow tool
Telehealth
Yesterday
Partnerships
Sojo Industries partners with Schreiber Foods on mobile manufacturing and next-gen track-and-trace platform
Supply Chain Tech
Yesterday
Product updates
Avetta unveils advanced safety, AI, and ESG features to Avetta One platform
Supply Chain Tech
Yesterday
Industry news
Epic Games CEO discusses potential blockchain use for Fortnite
Metaverse Experience Platforms
Yesterday
Product updates
Meta to release Meta AI for Quest 3 headset
Extended Reality
Yesterday
Product updates
Vayu Robotics unveils LiDAR-free last-mile delivery robot with AI foundation model
Last-mile Delivery Automation
Yesterday
Funding
Serve Robotics announces USD 15.0 million private placement to support operations and growth
Last-mile Delivery Automation
Yesterday
Funding
Akirolabs secures seven-digit grant from Investitionsbank Berlin and ERDF to develop AI capabilities for strategic procurement
Logistics Tech
Yesterday
Funding
Mytra raises USD 78 million in Series B funding to expand team and scale technology
Logistics Tech
Yesterday
Partnerships
Iteris receives USD 3.75 million contract from San Francisco Bay Area Metropolitan Transportation Commission
Smart Mobility Information
Yesterday
Precision Medicine

Precision Medicine

Jun 27, 2024

Bluejay Diagnostics raises USD 8.75 million in underwritten public funding to settle outstanding debt obligations and advance clinical R&D

Funding

  • Bluejay Diagnostics recently priced a firm commitment underwritten public offering. Aegis Capital Corp led the planning. The funds expected to be generated are ~USD 8.75 million (gross).

  • The funds will be used to repay an outstanding debt of USD 2.3 million and other various pursuits, including FDA approvals, clinical studies, other R&D activities, and general working capital requirements.

  • Bluejay Diagnostics is a medical diagnostics company specializing in rapid, near-patient testing systems to improve patient outcomes in critical care settings. The company's flagship Symphony System product facilitates whole-blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. Its primary product candidate, the IL-6 test for sepsis triage, supports medical decision-making. Bluejay also offers the ALLEREYE diagnostic test for allergic conjunctivitis and is developing cardiac biomarkers such as hsTNT and NT pro-BNP​.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.